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This was a prospective study comparing the cost implications between two carbon dioxide (CO2) absorbers, soda 
lime (Intersurgical) and AMSORB® PLUS. The study was conducted over two 4-week periods in two dedicated 
operating theatres using Datex Ohmeda Aestiva/5 anaesthetic machines. AMSORB® PLUS was used during the first 
four weeks and soda lime (Intersurgical) the following four weeks. General anaesthesia was administered as 
routinely done but fresh gas flow (FGF) during the maintenance phase was limited to a maximum flow of 2 L/min. 
The CO2 absorber was only changed when there was evidence of exhaustion. Total duration of anaesthesia, 
sevoflurane (bottles) and CO2 absorber (kg) consumption, and amount of waste product (kg) was calculated at the 
end of each study period. The total cost of delivering general anaesthesia was lower in the AMSORB® PLUS group, 
RM82.40 (USD19.89)/hour versus the soda lime group, RM91.50 (USD 22.09)/hour (p=0.17), which translates to a 
10% reduction in cost per hour. Reduction in sevoflurane consumption in the AMSORB® PLUS compared to the 
soda lime group was also not statistically significant (p=0.22). The only significant finding was the reduction in CO2 
absorber consumption in the AMSORB® PLUS group as compared to soda lime group (p=0.001). In conclusion, 
AMSORB® PLUS consumption was significantly reduced compared to that of soda lime. However, the use of 
AMSORB® PLUS did not significantly reduce sevoflurane consumption nor the total cost of delivering general 
anaesthesia. Given the superior safety profile, AMSORB® PLUS may be a suitable, cost-effective alternative to soda 
lime in the daily practice of anaesthesia.  
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Introduction 
 
General anaesthesia is commonly provided by 
delivering oxygen and anaesthetic gases (volatile 
anaesthetics) via the circle breathing system. The 
presence of a carbon dioxide (CO2) absorber allows 
for rebreathing of anaesthetic gases. This conserves 
anaesthetic gases, consequently decreasing cost and 
environmental pollution, whilst avoiding the hazards 
of CO2 rebreathing.  
 
Soda lime is a commonly used CO2 absorber in the 
circle breathing system. It consists of alkalis 
comprising 94% calcium hydroxide (Ca(OH)2), 5% 
sodium hydroxide (NaOH) and less than 0.1% 
potassium hydroxide (KOH),with a moisture content  
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of 15-19%. Silica (0.2%) prevents disintegration of the 
granules into powder and the addition of a dye changes 
the colour of the granules when soda lime is 
exhausted. One Kg of soda lime can absorb more than 
120 litres of CO2 (1). CO2 is primarily removed by 
Ca(OH)2, but NaOH and KOH assist in this process 
(2). 
 
However, desiccated soda lime is known to produce 
toxic compounds when it interacts with volatile 
anaesthetic agents (3). The degradation of sevoflurane 
produces formaldehyde (HCOH) and compound A. 
The latter has been reported to be nephrotoxic in rats. 
On the other hand, desflurane, enflurane and isoflurane 
produce carbon monoxide (CO) when degraded by 
desiccated or partially desiccated soda lime. Serious 
CO poisoning with neurological injury has been 
reported with desflurane anaesthesia. KOH may be the 
primary determinant in the production of CO (3). In 
addition to the potential production of these toxic 
compounds, degradation of volatile anaesthetics 
increases anaesthetic costs (3). 
 
New generations of CO2 absorbers have been 
developed to overcome these problems. 
AMSORB®PLUS is a strong alkali free (NaOH and 
KOH) CO2 absorber. The primary reaction is between 
CO2 and Ca(OH)2  forming calcium carbonate (CaCO3) 
and water. Calcium chloride (CaCl2) and calcium 
sulphate (CaSO4) prolong the life of Ca(OH)2  and 
increase its speed of absorption by maintaining granule 
strength and optimising hydration respectively. A 
colour indicator changes from white to violet when 
Ca(OH)2 is exhausted or desiccated. Studies have 
shown that CO2 absorption is not compromised in the 
absence of NaOH and KOH (2,4,5). 
 
In addition, AMSORB® PLUS unlike other CO2 
absorbers, does not degrade volatile agents. The 
formation of toxic compounds (particularly compound 
A and CO) is thus negligible or non-existent (6-12). 
Non-degradation of volatile anaesthetic agents 
resulting in no formation of toxic compounds may 
ensure patient safety while reducinganaesthetic 
consumption and cost. Another cost advantage of 
AMSORB® PLUS lies in the way it is disposed, 
where soda lime is disposed in healthcare waste while 
AMSORB® PLUS in domestic waste (3). The cost 
involved in managing domestic waste is lower than 
that of healthcare waste. 
 
However, AMSORB® PLUS is slightly more 
expensive per unit weight as compared to soda lime. 
To date,there has only been one study looking at the 
cost implications of replacing soda lime with 
AMSORB® PLUS   in clinical practice (3). The study 
showed an overall reduction of 28% in the cost of 
delivering general anaesthesia using  AMSORB® 
PLUS. The amount of AMSORB® PLUS used, and 
thus the amount of waste product was significantly 
lower compared to soda lime. Our study was modified 
from the prior study,with standardised methodology 
for the two groups (AMSORB® PLUS and soda lime) 
with respect to the duration of anaesthesia, usage of 
both study compounds (time of CO2 absorber granule 
replacement) and fresh gas flow (FGF), in the intent to 
compare the cost implications of soda lime versus 
AMSORB® PLUS in clinical practice. 
 
This study was carried out to compare the cost 
implications of soda lime versus AMSORB® PLUS in 
clinical practice, in terms of volatile anaesthetic and 
CO2 absorber consumption and CO2 absorber disposal. 
 
Materials and Methods 
 
This was a prospective study conducted after obtaining 
institutional ethics committee approval which was 
conducted over two 4-week periods.  AMSORB® 
PLUS was used during the first 4-week period 
followed by soda lime (Intersurgical) during the 
second 4-week period. The study was conducted in 
two dedicated elective operating theatres using the 
Datex Ohmeda Aestiva/5 anaesthetic machines with 
the circle breathing system. Loose granules (as 
opposed to prefilled canisters) of soda lime and 
AMSORB® PLUS were used.  
 
Only sevoflurane was used during the study, therefore 
the desflurane vapouriser was removed from the back 
bar. The vapourisers were maximally filled up at 
commencement of the study. Subsequent refills were 
done by the anaesthetic doctor in charge of that 
theatre. A new bottle of volatile anaesthetic agent 
(Sevoflurane, Baxter, 250 ml) was used for the first 
refill and subsequent new bottles were used when the 
previous one was finished. At the end of the study 
period, the vapourisers were maximally filled-up 
again to determine the total amount of volatile 
anaesthetic (based on number of bottles) that had been 
consumed. The empty bottles were placed in a 
specified box in the respective operating theatres and 
collected at the end of each day by an assigned 
anaesthetic technician.  
 
Newly replaced CO2 absorbers were used at 
commencement of the study and only replaced when it 
was exhausted (uniform colour change visible through 
the canister or when inspired CO2 was detected on the 
monitor). Replacement of the granules was done by 
the assigned anaesthetic technician and each 
replacement was documented. 
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General anaesthesia was delivered by multiple 
operators. Standard monitoring (non invasive blood 
pressure, pulse oximetry, lead II electrocardiography 
and capnography) was observed in all patients. The 
patients were pre-oxygenated (100% O2 at 8 L/min) to 
achieve an end tidal O2 of more than 85%. All patients 
were induced intravenously, while inhalational 
induction (sevoflurane 8% at fresh gas flows of 8 
L/min till the patient lost consciousness) was 
performed where indicated. The mode of induction of 
anaesthesia was documented in the data collection 
form. Anaesthesia was maintained with sevoflurane, 
targeting a minimum alveolar concentration (MAC) of 
1-1.3 in an oxygen / air mixture. The maximum fresh 
gas flow (FGF) allowed throughout the maintenance 
phase was 2 L/min. FGF during the maintenance phase 
and the total duration of anaesthesia (time from pre-
oxygenation till FGF was discontinued) was 
documented.  
 
At the end of the study period, the amount of CO2 
absorber (weight) and volatile anaesthetic (number of 
bottles) used was documented. Subsequently, the total 
cost of volatile anaesthetic and CO2 absorber 
consumption, in addition to waste disposal cost was 
determined. 
 
Statistical analysis was performed using the T-test to 
compare the mean cost, sevoflurane consumption, and 
CO2 absorber consumption between the two groups. A 





General anaesthesia was administered to seventy-four 
patients during the study period. There was no 
significant demographic difference between the two 
groups as shown in Table 1. 
 
For the AMSORB® PLUS group, the total duration of 
anaesthesia was 74.1 hours and mean duration of 
anaesthesia was 1.8 ± 0.8 hours. Inhalational induction  
 
was performed in six (14.6%) patients, and the mean 
FGF during the maintenance phase was 1.6 ± 
0.4L/min. On the other hand, the total duration of 
anaesthesia was 63.5 hours and mean duration of 
anaesthesia was 1.9 ± 1.0 hours for the soda lime 
group. Five (15.2%) of the patients were induced by 
inhalational technique and the mean FGF during the 
maintenance phase was 1.5 ± 0.5 L/min. There was no 
significant difference in terms of mean duration of 
anaesthesia and FGF between the two groups (p > 
0.05).  
 
The total cost calculated based on sevoflurane and 
CO2 absorber consumption, and disposal of waste 
product is shown in Table 2.  
 
For the AMSORB® PLUS group, the total cost for 
delivering general anaesthesia was RM 6104.80 (RM 
82.40/hour) and for the soda lime group the total cost 
was RM 5817.60 (RM 91.50/hour). Cost per patient 
was calculated based on cost per hour multiplied by 
the duration of anaesthesia for each patient. The mean 
cost per patient was RM 149.89 ± 64 and RM 176.30 ± 
97 for the AMSORB® PLUS and soda lime groups 
respectively, which was not significantly different (p = 
0.17). 
 
Total sevoflurane consumption was 17 bottles (4250 
ml, 57 ml/hour) in the AMSORB® PLUS group and16 
bottles (4000 ml, 62 ml/hour) in the soda lime group. 
 
Table 1: Demographic data. Values are expressed as mean ± 
SD or number (%) where appropriate. 
 
 




AMSORB® PLUS  Soda lime  














11 kg Negligible Negligible 16 kg 5.20 per kg 83.20 
Sevoflurane 
consumption 
17 bottles 338.40 per 
bottle 
5752.80 16 bottles 338.40  per 
bottle 
5414.40 
Total cost (RM)   6104.80   5817.60 
 AMSORB® PLUS  
 (n = 41)  
Soda lime  
(n = 33) 
Paediatric, Age (yrs) 
Adult, Age (yrs) 
6 (14.6), 6.5 ± 3.5 
35(85,4), 45 ± 19 
5 (15.2), 6.0 ± 3.0 
28 (84.8), 47 ± 17 
BMI (kg/m2) 25.3 ± 3.9 24.9 ± 3.8 
Gender  
    Male 







A comparison of soda lime (Intersurgical) with Amsorb® plus             Helmi AH et al. 
https://doi.org/10.17576/JSA.2016.0602.03 
 
Journal of Surgical Academia 2016; 6(2): 12-17   15 
 
Sevoflurane consumption per patient was calculated 
based on sevoflurane consumption/hour multiplied by 
duration of anaesthesia for each patient. The mean 
sevoflurane consumption per patient was 103.7 ml ± 
44.4 and 119.5 ml ± 66 for the AMSORB® PLUS and 
soda lime groups respectively, which was not 
significantly different (p = 0.2). As for CO2 absorber 
consumption, total consumption was 11 kg (148.6 
g/hour) for AMSORB® PLUS and 16 kg (251.6 
g/hour) for soda lime. CO2 absorber consumption per 
patient was calculated based on CO2 absorber 
consumption/hour multiplied by duration of 
anaesthesia for each patient. Thus, the mean CO2 
absorber consumption per patient was 269.2 ± 115 g 
and 483.6 ± 267g for the AMSORB® PLUS and soda 
lime groups respectively, which was significantly 




The cost of healthcare systems is increasing 
worldwide. The current economic climate has put 
pressures on healthcare systems and providers, 
anaesthesiologists included, to minimise cost without 
compromising patient safety. Anaesthetic drugs 
typically comprise approximately 5% of a hospital 
pharmacy budget (13). Although the cost of 
anaesthesia constitutes only a small proportion of the 
total healthcare cost, anaesthetic drug expenditure has 
been an important focus as part of this cost-
containment effort (14). In the analysis of 
perioperative costs, depending on the type of surgery, 
anaesthesia accounted for about 10-15% of the total 
cost of hospital stay. Inhalational agents accounted for 
5% of the total budget and 20% of all drug costs of an 
anaesthesia department (15). Employing cost saving 
measures when delivering inhalational agents could 
considerably reduce the anaesthetic department 
expenditure given its major contribution to the total 
drug cost. 
 
To date, only few studies have emphasised the need to 
improve alertness amongst practitioners with regards 
the cost of anaesthetic drugs, fluids and disposables, so 
as to optimise resources (16-18). When considering 
general anaesthesia, total intravenous anaesthesia is 
more costly than inhalational anaesthesia (19,20). 
Inhalational anaesthesia using low fresh gas flows has 
been proven to reduce volatile anaesthetic 
consumption thus is more cost effective (14,21,22, 23). 
However, low flow anaesthesia is not without 
problems, with the potential for CO formation which is 
inversely related to the flow rate (24,25). Ahmed et al. 
found a 28% reduction in the overall cost of delivering 
general anaesthesia using AMSORB® PLUS as 
compared to soda lime (3). However, the reduction in 
the amount of sevoflurane used in the AMSORB® 
PLUS group was not statistically significant (p = 
0.22). Nevertheless, the amount of AMSORB® PLUS 
used, thus the amount of waste product, was 
significantly lower compared to soda lime (p = 0.006).   
 
Our results were consistent with the above findings. 
The cost was lower, though not statistically significant 
in the AMSORB® PLUS group compared to the soda 
lime group (RM82.40/hour versus RM91.50/hour, p = 
0.17) which translates to a 10% reduction in cost per 
hour. The reduction in sevoflurane consumption in the 
AMSORB® PLUS group compared to the soda lime 
group was also not statistically significant (p = 0.22). 
The only significant finding in our study was the 
reduction in CO2 absorber used in the AMSORB® 
PLUS group compared to the soda lime group (p = 
0.001). This may be contributed by the fact that 
AMSORB®PLUS has superior CO2 absorption 
capacity (5). Bed packing of its granules is optimised 
with its range of granule size, permitting inter granular 
spaces between the larger granules to be filled in by 
smaller granules. This leads to reduced channeling of 
anaesthetic gas, which results in better CO2 absorption 
(4). 
 
This study had its limitations. Firstly, fresh gas flow 
rate, a major determinant of volatile anaesthetic 
consumption was standardised during the maintenance 
phase of anaesthesia where the maximum FGF 
allowed was 2 L/min. However, the FGF may have 
been manipulated to flows exceeding 2 L/min intra-
operatively to tailor to the patient’s requirement as and 
when necessary. This was further compounded by the 
involvement of multiple operators with inter-personnel 
variability in anaesthetic management.  Additionally, 
although inhalational induction was standardised at 8 
L/min, subsequent reduction and duration of gas flows 
above 2 L/min was not documented. Any modification 
in anaesthetic technique was not accounted for in the 
results as the changes were presumed to be transient. 
Secondly, sevoflurane consumption was based on the 
number of bottles used where the bottle was only 
disposed once the content was finished. However, the 
content of the last bottle may have not been 
completely emptied but was nevertheless still 
considered as one used bottle (regarded as 250 ml of 
sevoflurane consumption). Besides that, the 
sevoflurane bottle (Baxter) used is an open system 
bottle whereby the bottle cover has to be taken off and 
replaced with an adapter which fits into the vapouriser. 
No consideration was made for the lost vapour when 
the bottle was opened, and for any spillage of the 
liquid when filling the vapouriser. This would have 
overestimated the actual sevoflurane consumption. 
Thirdly, CO2 absorber was changed based on colour 
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change visible to the anaesthetic technician through 
the canister. Assessment of granule colour change in 
this manner did not take into consideration the actual 
colour of the granules in the core of the canister. This 
may have lead to unnecessary change of the granules 
and thus the cost incurred. Besides that, the violet 
colour of exhausted AMSORB®PLUS is not 
reversible because it does not contain strong alkali (4). 
However, the colour change of partially exhausted 
soda lime is reversible. When it is allowed to stand for 
a few hours, it appears to ‘regenerate’ as the surface 
carbonate is diluted by hydroxide ions migrating from 
within the granule (26). This may have lead to less 
frequent change of soda lime. Lastly, the cost of 
disposing AMSORB® PLUS was negligible but there 
was no actual calculation made to sum up the actual 
cost incurred. Thus the total cost of general 
anaesthesia using AMSORB® PLUS was concluded 
on the assumption that no cost was involved in 




AMSORB® PLUS consumption was significantly 
reduced compared to soda lime. However, the use of 
AMSORB® PLUS did not significantly reduce 
sevoflurane consumption nor the total cost of 
delivering general anaesthesia. Given its superior 
safety profile, AMSORB® PLUS may be a suitable, 
cost-effective alternative to soda lime in the daily 
practice of anaesthesia. 
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